198 related articles for article (PubMed ID: 19494006)
1. Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.
Arapovic J; Lenac T; Antulov R; Polic B; Ruzsics Z; Carayannopoulos LN; Koszinowski UH; Krmpotic A; Jonjic S
J Virol; 2009 Aug; 83(16):8198-207. PubMed ID: 19494006
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms.
Zhi L; Mans J; Paskow MJ; Brown PH; Schuck P; Jonjić S; Natarajan K; Margulies DH
Biochemistry; 2010 Mar; 49(11):2443-53. PubMed ID: 20166740
[TBL] [Abstract][Full Text] [Related]
3. Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60.
Arapović J; Lenac Rovis T; Reddy AB; Krmpotić A; Jonjić S
Mol Immunol; 2009 Nov; 47(1):114-22. PubMed ID: 19297023
[TBL] [Abstract][Full Text] [Related]
4. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
Hasan M; Krmpotic A; Ruzsics Z; Bubic I; Lenac T; Halenius A; Loewendorf A; Messerle M; Hengel H; Jonjic S; Koszinowski UH
J Virol; 2005 Mar; 79(5):2920-30. PubMed ID: 15709011
[TBL] [Abstract][Full Text] [Related]
5. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
[TBL] [Abstract][Full Text] [Related]
6. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
Slavuljica I; Busche A; Babić M; Mitrović M; Gašparović I; Cekinović D; Markova Car E; Pernjak Pugel E; Ciković A; Lisnić VJ; Britt WJ; Koszinowski U; Messerle M; Krmpotić A; Jonjić S
J Clin Invest; 2010 Dec; 120(12):4532-45. PubMed ID: 21099111
[TBL] [Abstract][Full Text] [Related]
7. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.
Lodoen MB; Abenes G; Umamoto S; Houchins JP; Liu F; Lanier LL
J Exp Med; 2004 Oct; 200(8):1075-81. PubMed ID: 15477345
[TBL] [Abstract][Full Text] [Related]
8. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
Front Immunol; 2018; 9():991. PubMed ID: 29867968
[TBL] [Abstract][Full Text] [Related]
9. The murine cytomegalovirus immunoevasin gp40/m152 inhibits NKG2D receptor RAE-1γ by intracellular retention and cell surface masking.
Lis N; Hein Z; Ghanwat SS; Ramnarayan VR; Chambers BJ; Springer S
J Cell Sci; 2021 Jun; 134(11):. PubMed ID: 34085696
[TBL] [Abstract][Full Text] [Related]
10. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features.
Šustić M; Cokarić Brdovčak M; Lisnić B; Materljan J; Juranić Lisnić V; Rožmanić C; Indenbirken D; Hiršl L; Busch DH; Brizić I; Krmpotić A; Jonjić S
Front Immunol; 2021; 12():681380. PubMed ID: 34168650
[TBL] [Abstract][Full Text] [Related]
11. NKG2D Signaling: The Immune Subversive Side of HDAC3.
Folgueras AR; Gonzalez S; López-Soto A
Trends Immunol; 2017 Mar; 38(3):151-153. PubMed ID: 28089218
[TBL] [Abstract][Full Text] [Related]
12. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40.
Pinto AK; Jamieson AM; Raulet DH; Hill AB
J Virol; 2007 Nov; 81(22):12564-71. PubMed ID: 17855532
[TBL] [Abstract][Full Text] [Related]
13. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S
J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899
[TBL] [Abstract][Full Text] [Related]
14. Ligands for murine NKG2D display heterogeneous binding behavior.
Carayannopoulos LN; Naidenko OV; Kinder J; Ho EL; Fremont DH; Yokoyama W
Eur J Immunol; 2002 Mar; 32(3):597-605. PubMed ID: 11857333
[TBL] [Abstract][Full Text] [Related]
15. The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.
Cédile O; Popa N; Pollet-Villard F; Garmy N; Ibrahim EC; Boucraut J
PLoS One; 2010 Oct; 5(10):e13466. PubMed ID: 20976056
[TBL] [Abstract][Full Text] [Related]
16. Viral MHC class I-like molecule allows evasion of NK cell effector responses in vivo.
Pyzik M; Dumaine A; Charbonneau B; Fodil-Cornu N; Jonjic S; Vidal SM
J Immunol; 2014 Dec; 193(12):6061-9. PubMed ID: 25392524
[TBL] [Abstract][Full Text] [Related]
17. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.
Krmpotic A; Hasan M; Loewendorf A; Saulig T; Halenius A; Lenac T; Polic B; Bubic I; Kriegeskorte A; Pernjak-Pugel E; Messerle M; Hengel H; Busch DH; Koszinowski UH; Jonjic S
J Exp Med; 2005 Jan; 201(2):211-20. PubMed ID: 15642742
[TBL] [Abstract][Full Text] [Related]
18. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice.
Rodriguez M; Sabastian P; Clark P; Brown MG
J Immunol; 2004 Nov; 173(10):6312-8. PubMed ID: 15528370
[TBL] [Abstract][Full Text] [Related]
19. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice.
Zafirova B; Mandarić S; Antulov R; Krmpotić A; Jonsson H; Yokoyama WM; Jonjić S; Polić B
Immunity; 2009 Aug; 31(2):270-82. PubMed ID: 19631564
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) NKG2D(+) T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1ε transgenic mice.
Lin Z; Wang C; Xia H; Liu W; Xiao W; Qian L; Jia X; Ding Y; Ji M; Gong W
Immunology; 2014 Mar; 141(3):401-15. PubMed ID: 24708417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
